Zelnorm Discontinued Due to Serious Risks

April 2007

Zelnorm withdrawn from market If you take Zelnorm to treat irritable bowel syndrome (IBS) or constipation, you may be at serious risk of heart attack or stroke. Following several clinical trials, the Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals discontinue selling the gastrointestinal (GI) drug, Zelnorm.

Zelnorm is used to treat chronic constipation in men and women under 65, as well as irritable bowl system in women. But clinical trials have proven that the risks outweigh the benefits for most patients.

Studies conducted through the manufacturer showed that angina, heart attack, and stroke were potential risks. Patients currently taking Zelnorm should consult their healthcare professionals to determine alternative treatments.

Think You Have a Case? Do You Need a Lawyer? How Much Does It Cost?	Related Links Dangerous Drug Information Dangerous Drugs Get FDA Approval
Have you suffered injuries due to Zelnorm? Contact us now for a FREE evaluation of your legal case.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Ohio and West Virginia, and we associate with experienced attorneys in other states. In addition, all drug-related litigation may involve co-counsel.

Source: "FDA Announces Discontinued Marketing of GI Drug, Zelnorm, for Safety Reasons." FDA Press Release. Mar 30, 2007.